The Biomedical Materials Innovation Task Unveiling Project is jointly organized by the Ministry of Industry and Information Technology, the State Food and Drug Administration and other departments. It aims to accelerate the development, production and application of biomedical materials in my country, promote collaborative innovation and research between the upstream and downstream of biomedical materials, and better support the high-quality development of the medical device industry. Its expected goal is to focus on key directions such as polymer materials, metallic materials, and inorganic non-metallic materials, recruit and select a group of units that master key core technologies and have strong innovation capabilities to focus on research, and focus on breaking through a group of iconic biomedical materials with advanced technology, strong innovation, and high clinical application value. The material properties will meet the requirements of clinical application, form stable and reliable large-scale production capabilities, and accelerate the implementation of applications in related downstream medical device product fields.

Jiangsu Baisaifei Biotechnology Co., Ltd. is a national-level 'specialized, special and innovative' small giant enterprise in the field of biomaterial surface modification technology. The company has assembled a team of high-end talents with an international perspective and interdisciplinary professional backgrounds such as biomaterials, chemical engineering, and mechanical automation. It has taken the lead in creating a technical service platform covering the entire industrial chain of functional coatings in China, providing customers with professional high-end functional coating overall solutions, including coating materials, coated components, coating equipment and coating testing instrument products. It also provides coating process adaptation services, coating coating ODM services, coating inspection and testing services (CMA&CNAS), and coating CDMO services. Cooperating customers include hundreds of domestic and foreign companies in health-related fields such as neurointervention, cardiovascular intervention/surgery, urology, digestion, extracorporeal life support, life science consumables and other health-related fields. The application of Bysaifei coating has obtained a large number of NMPA, FDA, and CE registration certifications.

Since its establishment, Baisaifei has gone through multiple rounds of financing and expansion, and now has a cumulative financing amount of more than 300 million yuan. It has nearly 25,000 square meters of R&D and production space, including a 100-ton medical coating material pilot and production base. With over 200 patent applications, it is the company with the most patents related to medical coatings in China. It has accumulated honors and qualifications such as the 25th China Patent Award, National High-tech Enterprise, and China’s Potential Unicorn Enterprise. Leading the first domestic industry standard for coating fastness of interventional medical devices and a number of coating evaluation standards that fill domestic gaps.